John Posner is a Visiting Professor in the Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, and is also an independent consultant in Pharmaceutical Medicine and Clinical Pharmacology. He is registered with the General Medical Council and is revalidated.

Professor Posner qualified with a BSc (Hons) and a PhD in pharmacology at King’s College London and MBBS at King’s College Hospital (KCH). He completed a residency in Internal Medicine in the Soroka Medical Centre, Beer Sheva, Israel, and entered the pharmaceutical industry in 1982. He served as Head of Clinical Pharmacology for The Wellcome Foundation from 1986-1995 and subsequently as a Director of Clinical Pharmacology at GlaxoWellcome. He continued to practise medicine and teach students on a part-time basis at KCH.

For the past 20 years, he has worked as an independent consultant on the exploratory development of a wide variety of drugs serving as medical advisor for the design, conduct and reporting of studies from ‘First-in-Human’ to ‘Proof of Concept’, preparation of regulatory submissions worldwide and serving on Data Monitoring Committees.

Professor Posner has extensive teaching commitments at King’s, including organising and facilitating MSc course modules, lecturing and running workshops. He has served as Chairman of the Board of Examiners of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians UK and established a Diploma and Certificate in Human Pharmacology and a Diploma in Experimental Therapeutics, which he continues to direct. He was elected to the Board of Trustees of the Faculty in 2016 and served until 2019. He is a Fellow of the British Pharmacological Society, has published extensively, served as an editor and author of The Textbook of Pharmaceutical Medicine and as an Executive Editor of the British Journal of Clinical Pharmacology.